High expression of MeCP2 in JC virus-infected cells of progressive multifocal leukoencephalopathy brains

Area of Science:

• Neuroscience
• Virology
• Molecular Biology

Background:

• Mutations in the methyl CpG binding protein 2 (MeCP2) gene are a primary cause of Rett syndrome.
• JC virus (JCV) causes progressive multifocal leukoencephalopathy (PML), a demyelinating disease of the brain.

Purpose of the Study:

• To investigate the relationship between MeCP2 gene expression and JCV infection in the brain.
• To determine if JCV infection influences MeCP2 expression in glial cells.

Main Methods:

• Examination of brain tissue from four PML patients.
• Immunohistochemical labeling for JCV proteins (VP1, agnoprotein, large T antigen) to confirm infection.
• Immunohistochemistry using an antibody against MeCP2 to assess its expression.
• Double immunolabeling to co-localize JCV large T antigen and MeCP2.

Main Results:

• MeCP2 was detected in neuronal nuclei in normal and uninfected PML brain tissue.
• In PML brains, intense MeCP2 immunolabeling was observed in enlarged glial nuclei within JCV-infected cells.
• Double labeling confirmed that JCV-infected glial nuclei expressed MeCP2.

Conclusions:

• MeCP2 is highly expressed in JCV-infected glial cell nuclei within PML brain tissue.
• JCV infection may play a role in regulating MeCP2 expression in glial cells.
• These findings may offer new insights into the pathogenesis of PML and MeCP2-related disorders.